Dynamic changes of serum hbv pgrna levels in patients with chronic hepatitis B treated with entecavir or peg-interferon

被引:1
|
作者
Yu, Xiaoqi [1 ]
Yu, Demin [1 ]
Chen, Peizhan [2 ]
Gong, Qiming [3 ]
Zhang, Xinxin [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Res Lab Clin Virol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp North, Translat Med Res Ctr, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China
关键词
D O I
10.1016/S0618-8278(19)30963-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-218
引用
收藏
页码:E490 / E490
页数:1
相关论文
共 50 条
  • [21] Peg-interferon plus nucleotide analogue in patients with chronic hepatitis B with low viral load reply
    Jansen, Louis
    Stelma, Femke
    de Niet, Annikki
    Reesink, Hendrik W.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (09): : 629 - 629
  • [22] Peg-interferon lambda Treatment induces robust innate and adaptive immunity in chronic hepatitis B Patients
    Phillips, Sandra
    Mistry, Sameer
    Riva, Antonio
    Cooksley, Helen
    Hadzhiolova-Lebeau, Tanya
    Plavova, Slava
    Katzarov, Krum
    Simonova, Marieta
    Zeuzem, Stephan
    Woffendin, Clive
    Chen, Pei-Jer
    Peng, Cheng-Yuan
    Chang, Ting-Tsung
    Lueth, Stefan
    De Knegt, Robert
    Choi, Moon-Seok
    Wedemeyer, Heiner
    Dao, Michael
    Kim, Chang-Wook
    Chu, Heng-Chen
    Wind-Rotolo, Megan
    Williams, Roger
    Cooney, Elizabeth
    Chokshi, Shilpa
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [23] SERUM AND URINARY NEOPTERIN LEVELS IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS-B TREATED WITH INTERFERON
    DAITO, K
    SUOU, T
    KAWASAKI, H
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1994, 83 (03): : 303 - 316
  • [24] A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a
    Chen, Xinyue
    Mao, Qianguo
    Xie, Yao
    Dou, Xiaoguang
    Xie, Qing
    Sheng, Jifang
    Gao, Zhiliang
    Zhou, Xiaoling
    Liu, Yingxia
    Zheng, Huanwei
    Zhang, Shuqin
    Li, Shibo
    Zhu, Fusheng
    Xu, Yuqin
    Zhang, Mingxiang
    Hu, Yaoren
    Chen, Xiaoping
    Huang, Yan
    Ren, Hong
    Jia, Jidong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (03) : 249 - 257
  • [25] Low serum HBsAg and HBV DNA levels identify strongest responders of pegylated interferon addition to entecavir in HBeAg positive chronic hepatitis B
    Liem, K. S.
    Hansen, B. E.
    Xie, Q.
    Chen, L.
    Brouwer, W. P.
    Chi, H.
    Guo, S.
    Qi, X.
    Zhang, N. P.
    Tabak, F.
    vanCampenhout, M. J.
    Janssen, H. L.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 27 - 28
  • [26] HCC incidence in patients treated with DAA for chronic hepatitis C compared to PEG-interferon/ribavirin treated patients: HORRID study.
    Siebenhuener, Alexander Rheinhard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [27] Peg-Interferon Alpha-2a versus Peg-Interferon Alpha-2b in Nonresponders with HCV Active Chronic Hepatitis: A Pilot Study
    Scotto, Gaetano
    Fazio, Vincenzina
    Fornabaio, Chiara
    Tartaglia, Alessandra
    Di Tullio, Rocco
    Saracino, Annalisa
    Angarano, Gioacchino
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2008, 28 (10): : 623 - 629
  • [28] Improved SVR rates in Southeast Asians with chronic hepatitis C treated with PEG-interferon and ribavirin
    Nguyen, TT
    Rothstein, KD
    Araya, V
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S144 - S144
  • [29] ENTECAVIR RESISTANCE IN ENTECAVIR NAIVE LAMIVUDINE TREATED CHRONIC HEPATITIS B PATIENTS
    Sayan, Murat
    Hulagu, Sadettin
    Akhan, Sila Cetin
    Senturk, Omer
    Meric, Meliha
    Cekmen, Mustafa
    MIKROBIYOLOJI BULTENI, 2009, 43 (03): : 425 - 432
  • [30] COULD PEG-INTERFERON AND RIBAVIRIN BE EFFECTIVE AND SAFE IN THALASSEMIC PATIENTS WITH CHRONIC HEPATITIS C?
    Madonia, S.
    Barone, R.
    Pantalone, G. Restivo
    Sinagra, E.
    Perricone, G.
    Renda, M. C.
    Piazza, A.
    Maggio, A.
    Cottone, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S351 - S352